Ophthalmology

Latest News

Eye on Pharma banner
Eye on Pharma: Simlandi US Launch; Ranibizumab Partnership; Expanded Access for Adalimumab Biosimilars

May 27th 2024

Alvotech and Teva have launched Simlandi in the US; Xbrane Biopharma and STADA Arzneimitel partner with Valorum Biologics to bring a ranibizumab biosimilar to the US; Boehringer Ingelheim and Celltrion take steps to expand access to their respective adalimumab biosimilars.

eye | Image credit: eevl - stock.adobe.com
FDA Approves First Eylea Biosimilars

May 20th 2024

money health | Image credit: utah51 - stock.adobe.com
Coherus Biosciences Cites Biosimilars as Main Drivers of 2023 Revenue Growth

March 14th 2024

Eye on Pharma banner
Eye on Pharma: Canadian Aflibercept Settlement; Sandoz Acquires Cimerli; Payer Chooses Cyltezo

March 6th 2024

Elder Asian woman with eye care treatment | Image Credit: Chinnapong - stock.adobe.com
QL1207 Biosimilar Shows Equivalent Efficacy, Safety to Aflibercept in Treating nAMD

March 5th 2024

Video Interviews
Podcasts
CFB podcast banner
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2024 MJH Life Sciences

All rights reserved.